Rajasthan ceases use of China-made rapid testing kits as most results invalid

Image
Press Trust of India Jaipur
Last Updated : Apr 21 2020 | 4:04 PM IST

The Rajasthan government on Tuesday stopped using the China-made rapid testing kits for coronavirus after they delivered inaccurate results.

The state's health minister Raghu Sharma said the kits gave only 5.4 per cent accurate results against the expectation of 90 per cent accuracy and therefore the kits were of no benefit, adding that the Indian Council of Medical Research (ICMR) has been informed about the issue.

"We have written to ICMR asking what to do. We are waiting for their response. The rapid test results were negative even on patients who tested positive in lab tests," the minister said.

A committee comprising heads of medicine and microbiology departments at the Sawai Man Singh government hospital here was set up by the government to examine the accuracy of the kits and it found that only 5.4 per cent test results were accurate.

"As per the advice of the committee, we have stopped testing from the rapid testing kits," the minister said.

He said 168 tests were conducted through rapid testing kits that were also used for testing of patients who have already tested positive for coronavirus in PCR based tests and the result was negative in their case too, which, the minister said, raised questions about the credibility of these kits.

"If the ICMR's response comes in our favour, the kits could be returned," he said.

Rajasthan had started conducting tests through rapid testing kits on Friday in the state's hotspots, starting from Jaipur.

Additional chief secretary medical and health Rohit Kumar Singh said the kits are China made. The state government got 30,000 kits through ICMR for free while 10,000 kits were purchased at a cost of Rs. 540 plus tax per kit.

The rapid testing kits, through which blood samples are tested, were aimed at speeding up screening and detection of suspected coronavirus patients as they take less time to show results in comparison to the swab-based tests carried out in pathology labs.

The rapid kit test was not a confirmatory test and PCR based test was required for confirmation of a positive result.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 21 2020 | 4:04 PM IST

Next Story